A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of the study is to assess the efficacy and safety of XP21279/Carbidopa in comparison to Sinemet as well as evaluate the pharmacokinetics (PK) of levodopa after administration of XP21279/Carbidopa and Sinemet and to explore exposure-response relationships in a subset of subjects.
Epistemonikos ID: 96dfe03cd5384e74e000872c36c21e9bcca21206
First added on: May 05, 2024